Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001437749-23-001839
Filing Date
2023-01-26
Accepted
2023-01-26 08:06:31
Documents
6
Effectiveness Date
2023-01-26

Document Format Files

Seq Description Document Type Size
1 FORM S-1MEF pbla20230125_s1mef.htm S-1MEF 41398
2 EXHIBIT 5.1 ex_468432.htm EX-5.1 25344
3 EXHIBIT 23.1 ex_468433.htm EX-23.1 2457
4 EXHIBIT 23.2 ex_468434.htm EX-23.2 2601
5 EXHIBIT FILING FEES ex_468435.htm EX-FILING FEES 22144
6 a1.jpg GRAPHIC 6874
  Complete submission text file 0001437749-23-001839.txt   104805
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-269421 | Film No.: 23553954
SIC: 2834 Pharmaceutical Preparations